Skip to main content

Volume 9 Supplement 2

Controversies in breast cancer

Short communications

Edited by William R Miller, Lesley J Fallowfield, Mitch Dowsett, Richard J Santen, James N Ingle

The Symposium and supplement were supported by unrestricted educational grants from AstraZeneca, Novartis, Pfizer and Roche

Controversies in Breast Cancer 2007.

Edinburgh, UK3-4 September 2007

Can't find what you're looking for?

Articles for this supplement are still being added to this new-look site. Please bear with us while we complete this work.

Submit manuscript

Follow

Annual Journal Metrics

  • 2022 Citation Impact
    7.4 - 2-year Impact Factor
    7.4 - 5-year Impact Factor
    1.764 - SNIP (Source Normalized Impact per Paper)
    2.408 - SJR (SCImago Journal Rank)

    2023 Speed
    20 days submission to first editorial decision for all manuscripts (Median)
    129 days submission to accept (Median)

    2023 Usage 
    2,432,781 downloads
    1,561 Altmetric mentions

Breast Cancer Research

ISSN: 1465-542X

Contact us